N-((S)-1-amino-3-(2,4-dichlorophenyl)propan-2-yl)-5-(2-(methylamino)pyrimidin-4-yl)thiophene-2-carboxamide

ID: ALA213618

PubChem CID: 16043304

Max Phase: Preclinical

Molecular Formula: C19H19Cl2N5OS

Molecular Weight: 436.37

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNc1nccc(-c2ccc(C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl)s2)n1

Standard InChI:  InChI=1S/C19H19Cl2N5OS/c1-23-19-24-7-6-15(26-19)16-4-5-17(28-16)18(27)25-13(10-22)8-11-2-3-12(20)9-14(11)21/h2-7,9,13H,8,10,22H2,1H3,(H,25,27)(H,23,24,26)/t13-/m0/s1

Standard InChI Key:  HHOVRZGUSBMKKU-ZDUSSCGKSA-N

Molfile:  

     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
    0.3451   -0.8227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3451    0.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3694    0.4148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1230    0.0792    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4556    1.2353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2626    1.4068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6751    0.6923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4956    0.6061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9805    1.2735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8311   -0.1476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6516   -0.2338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9871   -0.9875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8076   -1.0737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1365    0.4336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8010    1.1873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0596    0.4148    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7741    0.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7741   -0.8227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0596   -1.2352    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4885    0.4148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2030    0.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9175    0.4148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6319    0.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6319   -0.8227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3464   -1.2352    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.9175   -1.2352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2030   -0.8227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4885   -1.2352    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  2 16  1  0
  3  4  1  0
  5  3  2  0
  7  4  1  0
  6  5  1  0
  7  6  2  0
  7  8  1  0
  9  8  2  0
  8 10  1  0
 15  9  1  0
 11 10  2  0
 11 12  1  0
 11 14  1  0
 13 12  1  0
 15 14  2  0
 17 16  1  1
 17 18  1  0
 17 20  1  0
 18 19  1  0
 20 21  1  0
 21 22  1  0
 21 27  2  0
 23 22  2  0
 24 23  1  0
 24 25  1  0
 26 24  2  0
 27 26  1  0
 27 28  1  0
M  END

Associated Targets(Human)

AKT2 Tchem Serine/threonine-protein kinase AKT (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKACB Tchem cAMP-dependent protein kinase (PKA) (929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DOV13 (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAF1 Tclin Serine/threonine-protein kinase RAF (4169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3A Tclin Glycogen synthase kinase-3 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAMK2A Tchem CaM kinase II alpha (1938 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCA Tchem Protein kinase C alpha (5923 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT3 Tchem Serine/threonine-protein kinase AKT3 (3157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT2 Tchem Serine/threonine-protein kinase AKT2 (4301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 436.37Molecular Weight (Monoisotopic): 435.0687AlogP: 3.85#Rotatable Bonds: 7
Polar Surface Area: 92.93Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.02CX LogP: 3.70CX LogD: 2.08
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.25

References

1. Lin X, Murray JM, Rico AC, Wang MX, Chu DT, Zhou Y, Del Rosario M, Kaufman S, Ma S, Fang E, Crawford K, Jefferson AB..  (2006)  Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies.,  16  (16): [PMID:16765046] [10.1016/j.bmcl.2006.05.092]

Source